Follow the SenzaGen AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, SenzaGen AB has logged 0 reports. Market capitalisation: €172.3m. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
SenzaGen AB is a company focused on developing safety tests for chemicals and pharmaceuticals. It specializes in innovative solutions to assess the risks of allergies and skin irritations.